| KEGG pathways targeted by downregulated miRNAs |
| Adherence junction (hsa04520) |
| Biotin metabolism (hsa00780) |
| Glycosphingolipid biosynthesis, lacto- and neolactoseries (hsa00601) |
| Pancreatic secretion (hsa04972) |
| Protein processing in endoplasmic reticulum (hsa04141) |
| Ubiquitin mediated proteolysis (hsa04120) |
| Rap1 signaling pathway (hsa04015) |
| Thyroid hormone signaling pathway (hsa04919) |
| |
| KEGG pathways targeted by upregulated miRNAs |
| Axon guidance (hsa04360) |
| Mucin type O-glycan biosynthesis (hsa00512) |
| Valine, leucine, and isoleucine biosynthesis (hsa00290) |
| Circadian rhythm (hsa04710) |
| ECM-receptor interaction (hsa04512) |
| Gap junction (hsa04540) |
| Focal adhesion (hsa04510) |
| Estrogen signaling pathway (hsa04915) |
| Hippo signaling pathway (hsa04390) |
| FoxO signaling pathway (hsa04068) |
| mTOR signaling pathway (hsa04150) |
| Wnt signaling pathway (hsa04310) |
| Signaling pathways regulating pluripotency of stem cells (hsa04550) |
| TGF-beta signaling pathway (hsa04350) |
| PI3K-Akt signaling pathway (hsa04151) |
| Prion diseases (hsa05020) |
| Viral carcinogenesis (hsa05203) |
| Hepatitis B (hsa05161) |
| Chronic myeloid leukemia (hsa05220) |
| Glioma (hsa05214) |
| Melanoma (hsa05218) |
| Non-small cell lung cancer (hsa05223) |
| Pancreatic cancer (hsa05212) |
| Pathways in cancer (hsa05200) |
| Prostate cancer (hsa05215) |
| Proteoglycans in cancer (hsa05205) |
| Renal cell carcinoma (hsa05211) |
| Thyroid cancer (hsa05216) |
| Transcriptional misregulation in cancer (hsa05202) |
